Study Information

Title: A Pilot Study of Oncaspar¨ + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma External
Status: Recruiting participants
Conditions: T-Cell Lymphoma; Relapsed T-Cell Lymphoma; Refractory T-Cell Lymphoma
Interventions: Drug: PEG-L-asparaginase; Drug: Dexamethasone acetate
Institutions: Dana-Farber Cancer Institute, Massachusetts General Hospital
Health Topics: Non-Hodgkin Lymphoma

Contact Information


Dana Farber Cancer Institute
Boston, MA 02215
Phillippe Armand, MD
617-632-2305
PARMAND@PARTNERS.ORG
Massachusetts General Hospital
Boston, MA 02114
Jeremy Abramson, MD
617-726-8743
jabramson@partners.org